Centene (CNC)
(Delayed Data from NYSE)
$69.81 USD
-0.63 (-0.89%)
Updated Jun 7, 2024 04:00 PM ET
After-Market: $69.82 +0.01 (0.01%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth C Momentum A VGM
Brokerage Reports
0 items in cart
Centene Corporation [CNC]
Reports for Purchase
Showing records 521 - 540 ( 543 total )
Company: Centene Corporation
Industry: Medical - HMOs
Company: Centene Corporation
Industry: Medical - HMOs
Company: Centene Corporation
Industry: Medical - HMOs
Raising Price Target to $37 from $31 in Connection with 1Q11 Preview Based on Confidence in the Company''s Claims Clarity and Continued
Provider: WEDBUSH SECURITIES INC.
Analyst: JAMES S
Company: Centene Corporation
Industry: Medical - HMOs
The Week Ahead in Life Sciences - Upcoming Events for the Week of March 27
Provider: WEDBUSH SECURITIES INC.
Company: Centene Corporation
Industry: Medical - HMOs
FL Medicaid Expansion Proposal Introduced in the Senate; Includes ABD/LTC, 90% Minimum MLR, and Member Cost Sharing
Provider: WEDBUSH SECURITIES INC.
Analyst: JAMES S
Company: Centene Corporation
Industry: Medical - HMOs
GA RFP Delayed at Least 1 Yr; ABD Still a Possibility
Provider: WEDBUSH SECURITIES INC.
Analyst: JAMES S
Company: Centene Corporation
Industry: Medical - HMOs
Lots of Moving Pieces But $0.20 Boost From New Contracts Demonstrates Growth Potential
Provider: WEDBUSH SECURITIES INC.
Analyst: JAMES S
Company: Centene Corporation
Industry: Medical - HMOs
4Q10 Preview: Positive 2011 Outlook for Managed Care; Reiterate UNH and HUM as Top Picks
Provider: WEDBUSH SECURITIES INC.
Analyst: JAMES S
Company: Centene Corporation
Industry: Medical - HMOs
Updating Estimates for Ohio Rates; Continue to see Further Upside Potential If Utilization Remains Moderate
Provider: WEDBUSH SECURITIES INC.
Analyst: JAMES S
Company: Centene Corporation
Industry: Medical - HMOs
Updating Estimates for Ohio Rates, Continue to see Further Upside Potential If Utilization Remains Moderate
Provider: WEDBUSH SECURITIES INC.
Analyst: JAMES S
Company: Centene Corporation
Industry: Medical - HMOs
Low Risk to Remaining Rate Announcements; Continue to View Growth Opportunity as Undervalued.
Provider: WEDBUSH SECURITIES INC.
Analyst: JAMES S
Company: Centene Corporation
Industry: Medical - HMOs
Modest Medicare Growth in December; Expect Strong January Growth to be Driven by Gains.
Provider: WEDBUSH SECURITIES INC.
Analyst: JAMES S
Company: Centene Corporation
Industry: Medical - HMOs
Recent Contract Awards Bolster 2011 Outlook; Growth Opportunity Undervalued
Provider: WEDBUSH SECURITIES INC.
Analyst: JAMES S
Company: Centene Corporation
Industry: Medical - HMOs
Health Care Services - Managed Care -3Q10 Preview: See Largest Upside Potential at Humana,
Provider: WEDBUSH SECURITIES INC.
Analyst: JAMES S
Company: Centene Corporation
Industry: Medical - HMOs
Medicare PDP Premiums Increased 3.3%; Above Industry Trend of 1.4% Decrease.
Provider: WEDBUSH SECURITIES INC.
Analyst: JAMES S
Company: Centene Corporation
Industry: Medical - HMOs
Medicare PDP Benchmark Down 1.4% to $87.05, Below Historical Trend of 5% Increases
Provider: WEDBUSH SECURITIES INC.
Analyst: JAMES S
Company: Centene Corporation
Industry: Medical - HMOs
$0.03 Beat and $0.03-$0.05 Raise on Lower MLR Guidance; Positive Rate Outlook for GA, FL, and TX
Provider: WEDBUSH SECURITIES INC.
Analyst: JAMES S
Company: Centene Corporation
Industry: Medical - HMOs
2Q10 Preview: Healthcare Reform Likely to Overshadow Positive Fundamentals
Provider: WEDBUSH SECURITIES INC.
Analyst: JAMES S
Company: Centene Corporation
Industry: Medical - HMOs
Long-Term Growth Potential Undervalued; HC Reform Could Add $0.96-1.10EPS, FMAP Update.
Provider: WEDBUSH SECURITIES INC.
Company: Centene Corporation
Industry: Medical - HMOs
County Level Roll Up Analysis Shows Impact of Medicare Rate Regulations to Be More Material Than Originally Anticipated
Provider: WEDBUSH SECURITIES INC.